InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Stejbach Mark, Director. Insider active across 2 companies, notably Flexion Therapeutics Inc. Cumulatively, 6 filings have been published. History available since 24 June 2021. The latest transaction was filed on 13 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
6,518 shares0Common StockSEC:0001487937-26-000009:0
6,518 shares0Common StockSEC:0001487937-26-000009
12,631 shares@ US$8.5050.0% of flowCommon StockSEC:0001209191-21-065722
12,631 shares@ US$8.5050.0% of flowCommon StockSEC:0001209191-21-065722:0
4,500 shares0Common StockSEC:0001209191-21-043552
4,500 shares0Common StockSEC:0001209191-21-043552:0
6 of 6 declarations
About Stejbach Mark
Mark Stejbach is a Board Member of Flexion Therapeutics Inc. and Indivior Pharmaceuticals, Inc. He brings expertise in corporate strategy and governance. His role on the boards allows him to actively participate in strategic decision-making for these companies. Through his experience, he helps guide growth initiatives and strengthen their market positions.
